By bypassing a well-known gene implicated in almost one-third of all cancers and instead focusing on the protein activated by the gene, Duke University Medical Center researchers believe they may have found a new target for anti-cancer drugs.In experiments with human cells and animal models, the researchers studied the gene known as ‘Ras,’ which is integral in normal cell growth. [click link for full article]